What is the appropriate medication regimen for persistent migraine-like headache following a concussion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Post-Concussion Migraine Medication for Continued Pain

For persistent migraine-like headache following concussion, start with NSAIDs (ibuprofen 400-800mg or naproxen sodium 275-550mg) as first-line therapy, and if inadequate response after 2-3 headache episodes, escalate to triptans (sumatriptan, rizatriptan, or zolmitriptan) regardless of the specific headache phenotype. 1, 2, 3

Acute Treatment Algorithm

First-Line: NSAIDs

  • Ibuprofen 400-800mg every 6 hours (max 2.4g/day) 1
  • Naproxen sodium 275-550mg every 2-6 hours (max initial dose 825mg, avoid >1.5g/day) 1
  • Aspirin-acetaminophen-caffeine combination (strong recommendation for migraine treatment) [3, @20@]
  • Administer as early as possible during headache onset for maximum efficacy 1

Critical Caveat: Monitor closely for medication overuse—limit use to <2 days per week to avoid rebound headaches. Studies show 27% of post-concussion headache patients develop probable medication overuse headache 4. Acetaminophen alone is NOT effective for migraine-type headaches 1, 2.

Second-Line: Triptans (When NSAIDs Fail)

Strong evidence supports triptans for moderate-to-severe post-traumatic headache 3, 5:

  • Sumatriptan (oral 25-100mg or subcutaneous 6mg) - reaches peak concentration in 15 minutes subcutaneously, 70-82% effective 1
  • Rizatriptan (oral or absorbable wafer) - reaches peak in 60-90 minutes 1
  • Zolmitriptan (oral or intranasal) 3
  • Eletriptan or frovatriptan 3

Key principle: Trial a triptan for 2-3 headache episodes before abandoning. If one triptan fails, try a different one—individual response varies significantly 1. Preliminary evidence shows 72% of post-traumatic headaches resolved within 2 hours with sumatriptan, regardless of phenotype (migraine-like, probable migraine-like, or non-migraine-like) 5.

Contraindications: Ischemic vascular disease, vasospastic coronary disease, uncontrolled hypertension, significant cardiovascular disease 1.

Route Selection

Use non-oral routes (subcutaneous sumatriptan, intranasal zolmitriptan, or rizatriptan absorbable wafer) when nausea/vomiting is prominent 1, 2, 3. Treat nausea concurrently with metoclopramide or prochlorperazine—nausea itself is disabling and warrants treatment even without vomiting 1, 2.

When to Consider Preventive Therapy

Evaluate for preventive medication if: 2

  • ≥2 attacks per month producing disability lasting ≥3 days/month
  • Using abortive medication >2 times per week
  • Contraindication to or failure of acute treatments
  • Headache frequency ≥15 days per month (78% of persistent post-concussion headache patients meet this criterion) 4

Preventive Medication Options

First-line agents with strong evidence 2, 3:

  • Propranolol 80-240mg/day
  • Amitriptyline 30-150mg/day
  • Topiramate (for episodic and chronic migraine)
  • Valproate/divalproex sodium 500-1500mg/day

Newer agents showing promise:

  • CGRP antagonists (erenumab, fremanezumab, galcanezumab) - strong recommendation for episodic/chronic migraine 3. Open-label study showed 28% of persistent post-traumatic headache patients achieved ≥50% reduction in moderate-to-severe headache days with erenumab 6
  • OnabotulinumtoxinA for chronic migraine (≥15 headache days/month) - reduced cumulative headaches/week by 43.3% in post-traumatic headache 3, 6

Start low, titrate slowly over 2-3 months to assess efficacy, as clinical benefit takes time to manifest 2.

Critical Pitfalls to Avoid

  1. Opioid use: Avoid meperidine, butorphanol, or other opioids for chronic daily headaches—leads to dependency, rebound headaches, and loss of efficacy 1. Reserve only for severe, refractory acute episodes when sedation is acceptable 2.

  2. Medication overuse: The most common treatment failure pattern. Current data shows only 4% of post-concussion headache patients use triptans despite 88% having migraine-like phenotype, while 88% use non-opioid analgesics with 52% reporting lack of efficacy 4. This represents significant undertreatment with appropriate migraine-specific therapy.

  3. Delayed triptan trial: Don't wait too long to escalate from NSAIDs. If NSAIDs fail after 2-3 episodes, move to triptans promptly 1.

  4. Ignoring phenotype: While 88% of persistent post-concussion headaches present as migraine-like or probable migraine-like 4, treat based on phenotype characteristics (pressing/tightening suggests tension-type features; throbbing with nausea/photophobia suggests migraine features) 7, 8.

Multidisciplinary Considerations

For persistent symptoms beyond 4 weeks, integrate non-pharmacological interventions 7, 6, 8:

  • Early aerobic exercise programs (graded return to activity)
  • Cognitive behavioral therapy - showed significant improvements in headache-related disability (mean HIT-6 reduction of -3.4) in military veterans with post-traumatic headache 6
  • Biofeedback
  • Refer for multidisciplinary evaluation if headache persists, considering analgesic overuse as contributory factor 9

References

1
Guideline

management of the acute migraine headache.

American family physician, 2002

8
Research

A Comprehensive Approach to the Assessment and Management of Posttraumatic Headache.

Physical medicine and rehabilitation clinics of North America, 2025

Related Questions

What is the appropriate medical treatment for persistent post‑concussion headache?
After a head strike, I am experiencing persistent headache and dizziness; what immediate evaluation and management steps should I take?
What is the appropriate evaluation and management for a patient with intermittent post‑traumatic headache following a head injury?
How should a frontal headache persisting two weeks after a fall be managed in the absence of other symptoms?
How should I manage a patient three weeks after a head injury who has intermittent headaches and nausea, no photophobia or focal neurologic deficits, and normal head CT, laboratory studies, and vital signs?
How should I evaluate and manage a patient 6–7 months after axillary surgery who now has pain and mild swelling of the involved arm?
What is the recommended duration of ertapenem therapy for a urinary tract infection (UTI) that is susceptible to ertapenem?
How should I evaluate and manage a patient with pruritus, medial arm numbness, mild swelling, and no visible erythema?
What are alternative names for bacterial vaginosis?
What are the recommended sumatriptan dosing guidelines for acute migraine treatment in adults and adolescents, including oral, subcutaneous, and nasal spray formulations, and what precautions are needed for elderly patients, those with hepatic impairment, or those taking monoamine‑oxidase inhibitors?
Can invasive candidiasis be listed as the underlying cause of death on a death certificate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.